-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
-
Summary
-
Anebulo Pharmaceuticals, Inc. quarterly Liabilities and Equity history and growth rate from Q2 2020 to Q1 2024.
- Anebulo Pharmaceuticals, Inc. Liabilities and Equity for the quarter ending March 31, 2024 was $6M, a 58.5% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)